| |
Company
Roster
|
|
Total
Insiders : |
40 |
|
|
|
Total
Direct Shares :
|
11,384,859 |
|
|
Total
Indirect Shares :
|
14,805,567 |
| |
%
Held by Insiders:
|
34.89% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Conway Christopher M. |
SVP, Discovery and Development |
2017-08-31 |
0 |
|
0 |
| D Ambra Thomas E Phd |
Chairman, Board of Directors, Director |
2017-08-31 |
0 |
2003-08-07 |
0 |
| Hagen Kenneth Paul |
Director |
2017-08-31 |
0 |
2016-06-15 |
0 |
| Gutierrez Fuentes Luis Gerardo |
Director |
2017-08-31 |
0 |
2017-08-31 |
0 |
| Hagen Steven R |
SVP Manufacturing & Pharmaceut |
2017-08-31 |
0 |
2008-11-03 |
0 |
| Deming David H |
Director |
2017-08-31 |
0 |
2016-06-15 |
0 |
| Fine Margalit |
Executive Vice President, API |
2017-08-31 |
0 |
2017-02-08 |
0 |
| Oconnor Kevin |
Director |
2017-08-31 |
0 |
2004-05-19 |
0 |
| Maddaluna Anthony J |
Director |
2017-08-31 |
0 |
2016-02-04 |
0 |
| Napolitano Fernando |
Director |
2017-08-31 |
0 |
2017-02-08 |
0 |
| Svokos George |
Chief Operating Officer |
2017-07-05 |
123,086 |
|
0 |
| Marth William S |
President and CEO, Director |
2017-07-05 |
521,888 |
2012-06-06 |
0 |
| Boyer Milton |
SVP, Drug Product Manufacturin |
2017-07-05 |
38,910 |
|
0 |
| Roth Arthur J |
Director |
2017-05-26 |
52,575 |
|
0 |
| Ryan Una S |
Director |
2017-05-10 |
51,845 |
2006-10-30 |
0 |
| Henderson Lori M |
SVP, Secretary & Gen Counsel |
2017-03-02 |
61,995 |
|
0 |
| Ladin Felicia I |
SVP, Treasurer & CFO |
2017-02-17 |
58,936 |
2015-02-17 |
0 |
| Clessidra S.g.r. S.p.a. |
|
2016-07-11 |
7,051,295 |
|
0 |
| Jordan Veronica Gh |
Director |
2016-02-04 |
40,595 |
2006-10-30 |
0 |
| Dambra David |
10% Owner |
2015-12-17 |
16,290 |
2015-12-17 |
3,873,289 |
| D Ambra Constance M |
10% Owner |
2015-12-01 |
2,350,318 |
2003-08-07 |
0 |
| Leung Gabriel |
Director |
2015-03-02 |
31,316 |
|
0 |
| Nolan Michael M |
CFO |
2015-02-25 |
68,318 |
|
0 |
| Luther Michael A |
Senior VP, Discovery Services |
2015-02-04 |
31,271 |
|
0 |
| Sargent Bruce J |
Sr VP, Drug Discovery |
2013-06-02 |
55,386 |
|
0 |
| Dambra Geoffrey |
10% Owner |
2012-12-28 |
375,000 |
|
0 |
| Frost Mark T |
Chief Financial Officer |
2012-09-14 |
62,933 |
2005-03-11 |
0 |
| Anderson Paul S |
Director |
2011-06-01 |
13,353 |
2004-05-19 |
0 |
| Jennings William Steven |
Senior Vice President |
2010-03-08 |
17,000 |
|
0 |
| Tartaglia Anthony P |
Director |
2009-06-03 |
37,966 |
2004-05-19 |
0 |
| Kuhla Donald E |
Director |
2008-06-04 |
120,258 |
2003-08-27 |
0 |
| Evans Johnathan D |
VP Pharma Dev & Manu |
2007-03-23 |
20,000 |
2007-03-23 |
0 |
| Trova Michael P |
Sr. VP, Chemistry |
2006-05-05 |
65,488 |
2004-02-18 |
0 |
| Shultis Kenton L |
VP and GM, Organichem |
2006-05-05 |
45,523 |
|
0 |
| Grates James J |
VP, Operations |
2005-03-11 |
27,555 |
2004-02-19 |
0 |
| Haydu Frank |
Director |
2004-05-19 |
11,332 |
2004-02-12 |
0 |
| Waldek David P |
Chief Financial Officer |
2003-12-05 |
2,000 |
2003-12-05 |
0 |
| Meckler Harold |
VP, Science & Technology |
2003-12-02 |
32,427 |
2003-12-02 |
0 |
| Cable Stuart M |
10% Owner |
|
0 |
2015-06-01 |
3,880,983 |
| Mandarin Capital Management Secondary Sa |
|
|
0 |
2016-09-28 |
7,051,295 |
|
